These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection. Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094 [TBL] [Abstract][Full Text] [Related]
4. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection. Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923 [TBL] [Abstract][Full Text] [Related]
5. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step. Barbouche R; Decroly E; Kieny MP; Fenouillet E Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419 [TBL] [Abstract][Full Text] [Related]
6. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031 [TBL] [Abstract][Full Text] [Related]
7. Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function. Repke H; Gabuzda D; Palù G; Emmrich F; Sodroski J J Immunol; 1992 Sep; 149(5):1809-16. PubMed ID: 1354681 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120. Favero J; Corbeau P; Nicolas M; Benkirane M; Travé G; Dixon JF; Aucouturier P; Rasheed S; Parker JW; Liautard JP Eur J Immunol; 1993 Jan; 23(1):179-85. PubMed ID: 8419169 [TBL] [Abstract][Full Text] [Related]
9. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Delézay O; Hammache D; Fantini J; Yahi N Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for the interaction between focal adhesion kinase and CD4. Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954 [TBL] [Abstract][Full Text] [Related]
11. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures. Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594 [TBL] [Abstract][Full Text] [Related]
12. The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expression. Roland J; Berezov A; Greene MI; Murali R; Piatier-Tonneau D; Devaux C; Briant L DNA Cell Biol; 1999 Nov; 18(11):819-28. PubMed ID: 10595395 [TBL] [Abstract][Full Text] [Related]
13. The role of CD4 in HIV binding and entry. Sattentau QJ; Moore JP Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):59-66. PubMed ID: 7904348 [TBL] [Abstract][Full Text] [Related]
14. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation. Kalyanaraman VS; Rausch DM; Osborne J; Padgett M; Hwang KM; Lifson JD; Eiden LE J Immunol; 1990 Dec; 145(12):4072-8. PubMed ID: 1701782 [TBL] [Abstract][Full Text] [Related]
15. Is the V3 loop involved in HIV binding to CD4? Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233 [TBL] [Abstract][Full Text] [Related]
16. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120. Gizachew D; Moffett DB; Busse SC; Westler WM; Dratz EA; Teintze M Biochemistry; 1998 Jul; 37(30):10616-25. PubMed ID: 9692951 [TBL] [Abstract][Full Text] [Related]
17. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516 [TBL] [Abstract][Full Text] [Related]
18. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703 [TBL] [Abstract][Full Text] [Related]
19. Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120. Savarino A; Bensi T; Chiocchetti A; Bottarel F; Mesturini R; Ferrero E; Calosso L; Deaglio S; Ortolan E; Buttò S; Cafaro A; Katada T; Ensoli B; Malavasi F; Dianzani U FASEB J; 2003 Mar; 17(3):461-3. PubMed ID: 12551845 [TBL] [Abstract][Full Text] [Related]
20. Interaction of an anti-HIV peptide, T22, with gp120 and CD4. Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]